A randomized, double-blind trial comparing 5-aminolevulinic acid nanoemulsion (BF-200 ALA) with methyl-5-aminolevulinate (MAL) in daylight photodynamic therapy for actinic keratosis.

This article is protected by copyright. All rights reserved.
PMID: 30845350 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - March 6, 2019 Category: Dermatology Authors: Szeimies RM, Calzavara-Pinton P Tags: Br J Dermatol Source Type: research